W. Nathaniel Brennen
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 6
- Oncology top 5%
- Peptidase Inhibition and Analysis 10
- Cancer Cells and Metastasis 7
- Genetics top 5%
- Mesenchymal stem cell research 9
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 4
- Immunology top 10%
- Immunotherapy and Immune Responses 6
-
- Prostate Cancer Treatment and Research 16
-
- Neuropeptides and Animal Physiology 4
- Co-authors
- John T. IsaacsSamuel R. DenmeadeDaniel L.J. ThorekTimothy KruegerSaurabh AggarwalDavid RosenH. WangAaron M. LeBeau
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- United StatesDenmarkCanada
In The Last Decade
W. Nathaniel Brennen
48 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 505
- Oncology 908
- Genetics 282
- Molecular Biology 948
- Immunology 273
Countries citing papers authored by W. Nathaniel Brennen
This map shows the geographic impact of W. Nathaniel Brennen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Nathaniel Brennen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Nathaniel Brennen more than expected).
Fields of papers citing papers by W. Nathaniel Brennen
This network shows the impact of papers produced by W. Nathaniel Brennen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Nathaniel Brennen. The network helps show where W. Nathaniel Brennen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Nathaniel Brennen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 29 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 18 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 70 | |
| 12 | 2019 | 52 | |
| 13 | 2019 | 58 | |
| 14 | 2018 | 11 | |
| 15 | 2018 | 36 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 36 | |
| 18 | 2015 | 7 | |
| 19 | 2012 | 89 | |
| 20 | 2004 | 19 |
About W. Nathaniel Brennen
W. Nathaniel Brennen is a scholar working on Cancer Research, Genetics and Oncology, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Peptidase Inhibition and Analysis (10 papers), Mesenchymal stem cell research (9 papers), Cancer Cells and Metastasis (7 papers), Immunotherapy and Immune Responses (6 papers), Protease and Inhibitor Mechanisms (6 papers), Ubiquitin and proteasome pathways (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Cancer Research (505 citations), Oncology (908 citations) and Genetics (282 citations). W. Nathaniel Brennen has collaborated with scholars based in United States, Denmark and Canada. Frequent co-authors include John T. Isaacs, Samuel R. Denmeade, Daniel L.J. Thorek, Timothy Krueger, Saurabh Aggarwal, David Rosen, H. Wang, Aaron M. LeBeau, Susan L. Dalrymple and Alan K. Meeker. Their work appears in journals such as Nature Communications, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.